Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

329results about How to "Fast metabolism" patented technology

Novel adenine compound and use thereof

InactiveUS20060052403A1Suppressing systemic adverse effectFast metabolismBiocideOrganic chemistryOxygen atomCompound (substance)
A drug for topically administration which is effective as an antiallergic agent. The drug for topically administration contains as an active ingredient an adenine compound represented by the general formula (1): [wherein ring A represents a 6 to 10 membered, mono or bicyclic, aromatic hydrocarbon or a 5 to 10 membered, mono or bicyclic, aromatic heterocycle containing one to three heteroatoms selected among 0 to 2 nitrogen atoms, 0 or 1 oxygen atom, and 0 or 1 sulfur atom; n is an integer of 0 to 2; m is an integer of 0 to 2; R represents halogeno, (un)substituted alkyl, etc.; X1 represents oxygen, sulfur, NR1 (R1 represents hydrogen or alkyl), or a single bond; Y1 represents a single bond, alkylene, etc.; Y2 represents a single bond, alkylene, etc.; Z represents alkylene; and at least one of Q1 and Q2 represents —COOR10 (wherein R10 represents (un)substituted alkyl, etc.), etc.] or a pharmaceutically acceptable salt of the compound.
Owner:SUMITOMO DAINIPPON PHARMA CO LTD

Modified starch absorbable hemostasia material and preparation method thereof

The invention discloses an absorbable haemostatic material of a modified starch and a preparation method thereof. The haemostatic material is etherified modified starch or a composition which is formed by one or two or more than two of the etherified modified starch, cross-linked and composite modified starch, with a molecular weight of 15,000 to 2,000,000, a grain diameter of 10-1000Mu m and a water absorbency of 1 time to 100 times. The modified starch absorbable haemostatic material has the advantages that: the haemostatic material with biocompatibility is directly applied to bloody surface of wound to stop bleeding immediately, obviously increase the water absorbency and the water absorbing speed and have more viscosity and viscidity, thereby simultaneously blocking up damaged tissues and blood vessels while stopping bleeding. The haemostatic material is easy to swell or dissolve in water and after stopping bleeding, normal saline is used for washing to eliminate the haemostatic material not participating in stopping bleeding, thus reducing residues in the body, being beneficial to wound healing, and avoiding pains caused by unclosing pledget and bandage. The haemostatic material has the physical and chemical properties of stability, difficult decomposition, long guarantee period, convenient storage, high pressure resistance, low pressure resistance, high temperature resistance, low temperature resistance and difficult change.
Owner:BEIJING UNIVERSAL LIKANG TECH CO LTD

Biocompatibility pre-gelatinized modified starch and preparation thereof

The invention relates to a biocompatible pre-gelatinized modified starch. The water absorbency is not less than one time, and the biocompatible pre-gelatinized modified starch is taken as biocompatible hemostatic material, biocompatible anti-blocking material, biocompatible tissue-healing promoting material, biocompatible surgical sealant or biocompatible wound closure tissue glue. The invention has the advantages that the biocompatible pre-gelatinized modified starch is directly acted on the wounded area with blood for immediately stopping bleeding, has obviously increased water absorbency and speed of water absorption and greater viscosity and stickiness and further plays the role in preventing the tissue and the blood vessel from being damaged during the process of stopping bleeding; the modified starch is easy to swell or dissolve in water, and is washed by normal saline after the bleeding stopping so as to reduce the residual in the body, to be favorable for wound healing and to avoid the pain due to tearing the gauze and the bandage out; the pre-gelatinized modified starch has the actions of bacterial resistance and anti-inflammatory; and the pre-gelatinized modified starch is stable, not easy to decompose, long in guarantee period, convenient for storage, resistant at high pressure and low pressure, resistant at high temperature and low temperature and not easy to change the physicochemical characteristics.
Owner:纪欣

Bioaugmentation treatment technology of high ammonia nitrogen wastewater

The invention relates to a bioaugmentation treatment technology of the high ammonia nitrogen wastewater. The treatment technology is characterized in that under the condition that dissolved oxygen exists in the high ammonia nitrogen wastewater, an aerobic pool, an aerobic filter and a membrane pool are established, wherein by utilizing the metabolism of the aerobic microorganism, high concentration of organic substances are degraded, the organic substances with high molecular weight and energy are converted to substances with low molecular weight and energy; the aerobic pool adopts internal circulation and large-scale external circulation hydraulic agitation; and the aerobic filter is filled with novel fixed enzyme-floating filler and immobilized microorganism and microporous aeration and jet aeration are combined for aeration, thus the flow pattern of the nitrification filter is improved. Compared with the prior art, the system of the invention has high sludge concentration and the corresponding volume loading is also high, thus the floor space is small and the capital cost is low; the conversion rate and utilization rate of atmospheric oxygen is high, the effect of mass transfer is good, the anti-shock loading capability of the system is high, the effluent quality is stable; the operating cost is low; the density is increased relatively, the solid-liquid separating effect is good and the yield of excess sludge is low.
Owner:SHANGHAI HONESS ENVIRONMENTAL TECH CORP

Ester combination local anesthetic

InactiveUS20050137177A1Low risk of toxicityRapid actionBiocideAnimal repellantsPain durationChemical toxicity
The present invention provides compositions and methods for improved local anesthesia and / or analgesia, in which onset of action is rapid, the risk of toxicity is low, and the effect is sustained. More particularly, the present invention provides a combination of at least two ester anesthetics for administration to a subject, where at least one ester anesthetic provides a rapid onset of action and at least one ester anesthetic provides sustained activity. The compositions of the present invention are useful for the production of analgesia and / or anesthesia and are particularly useful for the prophylaxis and / or treatment of pain.
Owner:THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIV

Shewanella-decolorationis-based microbial fuel cell and using method thereof

The invention discloses a Shewanella-decolorationis-based microbial fuel cell and a using method thereof. The microbial fuel cell comprises an anode chamber, a cathode chamber, an anode electrode, a cathode electrode, a proton permeation film and an external circuit, wherein a microorganism is inoculated in the anode chamber; the anode chamber is also filled with a culture solution and electron donors of the microorganism; the cathode chamber is filled with cathode reaction liquid; and the microorganism is Shewanella decolorationis. The microbial fuel cell takes the Shewanella decolorationis as an anode microorganism; and the Shewanella decolorationis has extremely high environmental suitability and a variety of breathing mechanisms. In the nutrient-rich anode culture solution, the Shewanella decolorationis can metabolize and reproduce quickly, and consume dissolved oxygen to maintain an anaerobic environment around the anode electrode in an extremely short time; therefore, the step of blowing nitrogen to manufacture the anaerobic environment and keep an anaerobic reaction condition of a common microbial fuel cell before starting or in operation can be eliminated; an operation operating method is simplified; and the Shewanella-decolorationis-based microbial fuel cell has a good application prospect in the treatment and the recycling of environmental pollutants.
Owner:GUANGDONG INST OF MICROORGANISM

Meal replacement jelly powder and preparation method thereof

The invention relates to meal replacement jelly powder and a preparation method thereof. The meal replacement jelly powder comprises the following components in parts by weight: 20-35% of polydextrose, 1-8% of isomaltulose, 5-15% of konjac glucomannan, 4-10% of carageenan, 0.1-1% of gamma aminobutyric acid and 0.3-1.4% of collagen. According to the meal replacement jelly powder and the preparation method, a jelly form is adopted, so that the product has a good taste and an attractive appearance. Satiety is improved by adding a substance with a meal replacement effect into the meal replacement jelly powder, so that the purpose of slimming is achieved.
Owner:BEIJING COMPETITOR SPORTS SCI & TECH

Fermentation method for improving yield of isoleucine

The invention discloses a fermentation method for improving the yield of isoleucine. The fermentation method comprises the following steps: culturing microorganisms, fermenting, separating fermentation liquor, carrying out ion exchange on fermentation supernatant, deaminizing with a deamination tower, decolorizing with activated carbon and crystallizing by evaporating. Because the corn steep liquor which serves as a hydrolysis liquor in the culture medium and accounts for 40% of the total weight of the culture medium replaces the hydrochloric acid adopted by the traditional method to regulate the pH value, the corrosion of the hydrochloric acid to the stainless steel tank is avoided. In addition, because biotin and VB1 are used as growth factors in the process, the viscosity of the fermentation liquor can be reduced, the respiratory metabolism of the microorganisms can be promoted, and the down-stream finished product can be extracted easily. By adopting the fermentation method disclosed by the invention, a good fermentation index can be achieved, the yield of the isoleucine which is a metabolite can be improved significantly, the average yield of the isoleucine can be up to 36.9g/L and can be increased by 30% compared with that of the metabolite isoleucine obtained by adopting the original method, the conversion rate of the metabolite isoleucine can be increased by 2-4%, and the fermentation cycle can be shortened by 10 hours.
Owner:HENAN JULONG BIOLOGICAL ENG CO LTD

Scientific weight losing fully nutritional powder composition having satiety

The present invention discloses a scientific weight losing fully nutritional powder composition having satiety and belongs to the field of special dietary food processing. The composition is characterized by comprising the following components in percentages by mass: oat dietary fibers, plantago ovate seed shell powder, a garcinia cambogia fruit extract, a green coffee bean extract, sodium caseinate and mogrosides, and is also prepared by mixing the following raw materials: soybean protein isolate, plant fat powder, compound vitamins and compound minerals. By adding the oat dietary fibers, plantago ovate seed shells, sodium caseinate and mogrosides, the composition reaches effects of promoting satiety, moistening intestines and relaxing bowels. By adding the garcinia cambogia fruit extract and coffee bean extract, the composition has effects of inhibiting appetite and promoting fat metabolism. By adding the soybean protein isolate, plant fat powder, compound vitamins and compound minerals, the composition can supplement body with proteins, fats, vitamins and minerals, enables the body to reach purposes of being health and losing weight, and is especially suitable for populations with obesity and overweight.
Owner:MEILU BIOTECH CO LTD

High-energy instant food

The invention provides a high-energy instant food which is prepared from the following raw materials in parts by weight: 10 to 15 parts of grain flour, 5 to 40 parts of soybean flour, 5 to 40 parts of cooked whole grain, 5 to 20 parts of vegetable oil, 2 to 15 parts of syrup, 1 to 5 parts of sucrose, 1 to 5 parts of capric glyceride, 0.5 to 2 parts of soybean lecithin, 0.2 to 5 parts of vegetable powder, 0.1 to 2 part of salt, 0.1 to 0.5 part of compound vitamin, 0.1 to 0.5 part of compound mineral, 0.1 to 0.5 part of methionine, 0.1 to 0.3 part of L-carnitine and 0.1 to 0.5 part of edible essence. The product has the characteristics of high energy (more than 5kilocalories / gram), good taste, comprehensive nutrition, oxygen deficiency resistance, rapid, long-term and continuous energy supply and the like.
Owner:XIAN LI BANG CLINICAL NUTRITION CO LTD

Method for sectional regulation and control for continuous strain culture

The invention discloses a method for sectional regulation and control for continuous strain culture. By adopting the method, nutrient substances are continuously replenished into a fermentation liquidto maintain strain metabolism, and at the same time, the fermentation liquid is continuously led out and is fed into a serial fermentation tank for further fermentation; to increase the strain metabolism velocity, parameters such as dissolved oxygen, pH values and replenished material constitution are respectively regulated and controlled at different stages. By adopting the method, the times ofstrain culture and equipment cleaning are reduced, the production process can be simplified, and the fermentation cost can be reduced. In addition, due to sectional regulation and control on the fermentation process, the yield of rhamnolipid can be increased, the fermentation production efficiency can be improved, the product batch stability can be improved, and the method is easily applied to industrial production.
Owner:WANHUA CHEM GRP CO LTD

Heterocyclic indene derivatives and their radioisotope labeled compounds for imaging beta-amyloid deposition

The invention is directed to heterocyclic indene derivatives useful for β-amyloid plaque imaging, their radiolabeled compounds and their preparation methods. The compounds of the invention are easily labeled with radioisotopes and have high affinities to β-amyloid depositions, thus they facilitate diagnosis of Alzheimer's disease by imaging the distribution of β-amyloid depositions.
Owner:SEOUL NAT UNIV R&DB FOUND
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products